HLN
Haleon plc NYSE$9.24
Mkt Cap $41.1B
52w Low $8.71
19.6% of range
52w High $11.42
50d MA $10.04
200d MA $9.81
P/E (TTM)
26.1x
EV/EBITDA
14.7x
P/B
2.5x
Debt/Equity
0.5x
ROE
—
P/FCF
17.1x
RSI (14)
—
ATR (14)
—
Beta
0.33
50d MA
$10.04
200d MA
$9.81
Avg Volume
8.1M
About
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include P…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 0.25 | 0.26 | +3.4% | 10.44 | +2.9% | +3.1% | +6.0% | +4.1% | +1.6% | +0.3% | -6.1% | — |
| Oct 30, 2025 | AMC | 0.24 | 0.14 | -42.8% | 9.18 | +0.4% | +1.0% | +2.2% | +1.5% | +1.4% | +2.5% | +6.8% | — |
| Aug 7, 2025 | AMC | 0.24 | 0.08 | -67.3% | 9.46 | +0.3% | +0.8% | +0.1% | +1.3% | +2.4% | +2.5% | +3.0% | — |
| Feb 27, 2025 | AMC | 25.25 | 0.05 | -99.8% | 9.79 | +4.2% | +4.0% | +8.1% | +9.0% | +7.7% | +6.1% | +5.1% | — |
| Oct 31, 2024 | AMC | 0.11 | 0.14 | +27.3% | 9.69 | +1.1% | +0.4% | +0.7% | +0.8% | -1.5% | -0.9% | -0.2% | — |
| May 1, 2024 | AMC | 0.11 | 0.12 | +9.1% | 8.35 | -0.8% | -0.4% | -0.6% | -1.3% | -0.2% | -1.9% | +1.1% | — |
| Feb 29, 2024 | AMC | 10.27 | 6.54 | -36.3% | 8.56 | -1.5% | -1.3% | -2.9% | -2.7% | -2.7% | -0.1% | -2.6% | — |
| Aug 2, 2023 | AMC | 0.22 | 0.08 | -63.5% | 8.32 | +0.0% | +0.6% | -0.7% | +0.6% | +1.1% | +1.9% | -2.6% | — |
| Mar 2, 2023 | AMC | 0.23 | 0.21 | -9.7% | 7.63 | +0.8% | +1.8% | +2.9% | +2.0% | +2.1% | +1.4% | +7.1% | — |
| Sep 20, 2022 | AMC | 0.22 | 0.22 | -1.6% | 5.99 | +1.0% | -1.5% | +1.3% | -1.0% | +1.3% | -2.3% | +0.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 | Barclays | Upgrade | Equal Weight → Overweight | — | $10.33 | $10.36 | +0.3% | +1.3% | +0.4% | +0.9% | -0.2% | -0.3% |
| Sep 16 | Barclays | Downgrade | Overweight → Equal Weight | — | $9.68 | $9.35 | -3.4% | -4.1% | -2.9% | -4.5% | -5.4% | -7.0% |
| Sep 20 | Morgan Stanley | Maintains | Overweight → Overweight | — | $10.46 | $10.45 | -0.1% | +0.6% | +1.6% | +1.9% | +1.2% | +1.2% |
| Mar 26 | Argus | Maintains | Buy → Buy | — | $8.43 | $8.41 | -0.2% | -0.2% | +1.2% | +0.7% | -1.1% | -1.8% |
| Apr 6 | Argus | Upgrade | Hold → Buy | — | $8.63 | $8.81 | +2.1% | +3.9% | +2.5% | +1.6% | +2.3% | +1.4% |
| Sep 28 | Argus | Maintains | Hold → Hold | — | $5.85 | $5.86 | +0.2% | +2.2% | +4.4% | +4.1% | +5.0% | +6.7% |
| Jul 29 | Deutsche Bank | Maintains | Hold → Hold | — | $7.00 | $6.92 | -1.1% | +0.4% | +5.3% | +5.7% | +4.3% | +4.4% |
Data updated apr 26, 2026 10:51am
· Source: massive.com